整合转录组学数据和孟德尔随机化分析揭示潜在的新的败血症相关靶点。

IF 3.5 4区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Wenting Tao, Liang Chen
{"title":"整合转录组学数据和孟德尔随机化分析揭示潜在的新的败血症相关靶点。","authors":"Wenting Tao, Liang Chen","doi":"10.2174/0109298673370740250403141421","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Sepsis remains a leading cause of global morbidity and mortality.</p><p><strong>Objective: </strong>To identify candidate biomarkers that may be mechanistically related to the pathogenesis of sepsis.</p><p><strong>Methods: </strong>The Gene Expression Omnibus database was leveraged to identify differentially expressed genes (DEGs) between the healthy control and septicemia groups. Genes causally related to sepsis were probed through the integration of GWAS and expression quantitative trait loci (eQTL) data in a two-sample Mendelian randomization (MR) analysis. A set of key sepsis-related genes was then selected based on the overlap between these putative causal genes and the DEGs. These genes were then subjected to enrichment analyses, testing set validation, and analyses of their expression dynamics in clinical samples.</p><p><strong>Results: </strong>An examination of the overlap between 228 sepsis-related DEGs identified in the training dataset and 275 candidate causal genes linked to sepsis derived from the MR analysis led to the selection of four overlapping (SLC22A15, IL5RA, HDC, and SLC46A2) that may play a key role in sepsis. Enrichment analyses indicated that these genes were involved in the regulation of histidine metabolism and immune/inflammatory responses. In immune cell infiltration analyses, these genes were positively correlated with inflammatory response activation and the suppression of adaptive immunity. Consistent findings were obtained through qPCR verification in clinical samples.</p><p><strong>Conclusion: </strong>These results offer potential insight into the mechanisms that govern septicemia and thus suggest a promising series of candidates that may be amenable to targeting to prevent or treat sepsis more effectively.</p>","PeriodicalId":10984,"journal":{"name":"Current medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Integrating Transcriptomic Data and Mendelian Randomization Analyses Reveals Potentially Novel Sepsis-related Targets.\",\"authors\":\"Wenting Tao, Liang Chen\",\"doi\":\"10.2174/0109298673370740250403141421\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Sepsis remains a leading cause of global morbidity and mortality.</p><p><strong>Objective: </strong>To identify candidate biomarkers that may be mechanistically related to the pathogenesis of sepsis.</p><p><strong>Methods: </strong>The Gene Expression Omnibus database was leveraged to identify differentially expressed genes (DEGs) between the healthy control and septicemia groups. Genes causally related to sepsis were probed through the integration of GWAS and expression quantitative trait loci (eQTL) data in a two-sample Mendelian randomization (MR) analysis. A set of key sepsis-related genes was then selected based on the overlap between these putative causal genes and the DEGs. These genes were then subjected to enrichment analyses, testing set validation, and analyses of their expression dynamics in clinical samples.</p><p><strong>Results: </strong>An examination of the overlap between 228 sepsis-related DEGs identified in the training dataset and 275 candidate causal genes linked to sepsis derived from the MR analysis led to the selection of four overlapping (SLC22A15, IL5RA, HDC, and SLC46A2) that may play a key role in sepsis. Enrichment analyses indicated that these genes were involved in the regulation of histidine metabolism and immune/inflammatory responses. In immune cell infiltration analyses, these genes were positively correlated with inflammatory response activation and the suppression of adaptive immunity. Consistent findings were obtained through qPCR verification in clinical samples.</p><p><strong>Conclusion: </strong>These results offer potential insight into the mechanisms that govern septicemia and thus suggest a promising series of candidates that may be amenable to targeting to prevent or treat sepsis more effectively.</p>\",\"PeriodicalId\":10984,\"journal\":{\"name\":\"Current medicinal chemistry\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-04-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current medicinal chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2174/0109298673370740250403141421\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0109298673370740250403141421","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:脓毒症仍然是全球发病率和死亡率的主要原因。目的:寻找可能与脓毒症发病机制相关的候选生物标志物。方法:利用基因表达Omnibus数据库鉴定健康对照组与败血症组之间的差异表达基因(DEGs)。在双样本孟德尔随机化(MR)分析中,通过整合GWAS和表达数量性状位点(eQTL)数据来探索与脓毒症相关的基因。然后根据这些假定的致病基因和deg之间的重叠选择一组关键的败血症相关基因。然后对这些基因进行富集分析,测试集验证,并分析其在临床样品中的表达动态。结果:对训练数据集中鉴定的228个败血症相关deg与MR分析得出的275个与败血症相关的候选致病基因之间的重叠进行了检查,选择了4个重叠基因(SLC22A15、IL5RA、HDC和SLC46A2),可能在败血症中发挥关键作用。富集分析表明,这些基因参与组氨酸代谢和免疫/炎症反应的调节。在免疫细胞浸润分析中,这些基因与炎症反应激活和适应性免疫抑制呈正相关。在临床样本中进行qPCR验证,结果一致。结论:这些结果为败血症的控制机制提供了潜在的见解,从而提出了一系列有希望的候选药物,可以更有效地预防或治疗败血症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Integrating Transcriptomic Data and Mendelian Randomization Analyses Reveals Potentially Novel Sepsis-related Targets.

Background: Sepsis remains a leading cause of global morbidity and mortality.

Objective: To identify candidate biomarkers that may be mechanistically related to the pathogenesis of sepsis.

Methods: The Gene Expression Omnibus database was leveraged to identify differentially expressed genes (DEGs) between the healthy control and septicemia groups. Genes causally related to sepsis were probed through the integration of GWAS and expression quantitative trait loci (eQTL) data in a two-sample Mendelian randomization (MR) analysis. A set of key sepsis-related genes was then selected based on the overlap between these putative causal genes and the DEGs. These genes were then subjected to enrichment analyses, testing set validation, and analyses of their expression dynamics in clinical samples.

Results: An examination of the overlap between 228 sepsis-related DEGs identified in the training dataset and 275 candidate causal genes linked to sepsis derived from the MR analysis led to the selection of four overlapping (SLC22A15, IL5RA, HDC, and SLC46A2) that may play a key role in sepsis. Enrichment analyses indicated that these genes were involved in the regulation of histidine metabolism and immune/inflammatory responses. In immune cell infiltration analyses, these genes were positively correlated with inflammatory response activation and the suppression of adaptive immunity. Consistent findings were obtained through qPCR verification in clinical samples.

Conclusion: These results offer potential insight into the mechanisms that govern septicemia and thus suggest a promising series of candidates that may be amenable to targeting to prevent or treat sepsis more effectively.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current medicinal chemistry
Current medicinal chemistry 医学-生化与分子生物学
CiteScore
8.60
自引率
2.40%
发文量
468
审稿时长
3 months
期刊介绍: Aims & Scope Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信